FDA Censures Compounding Pharmacies
A 2002 landmark study found that HRT drugs may raise a woman’s risk of heart attack, stroke or breast cancer which prompted may woman to stop.
Many instead became interested in bio-identical hormones. Compounding pharmacies emerged as a preferred supply of these hormones. But then, according to the FDA, they started making false claims online.
The FDA told 7 pharmacies to stop making those claims.
The FDA began the crackdown after hormone maker, Wyeth asked the agency to take action. Wyeth makes Premarin and Prempro and saw sales cut in half after the 2002 study.
Posted in General
Comments are currently closed.